322 related articles for article (PubMed ID: 31350244)
1. Sino Longitudinal Study on Cognitive Decline (SILCODE): protocol for a Chinese longitudinal observational study to develop risk prediction models of conversion to mild cognitive impairment in individuals with subjective cognitive decline.
Li X; Wang X; Su L; Hu X; Han Y
BMJ Open; 2019 Jul; 9(7):e028188. PubMed ID: 31350244
[TBL] [Abstract][Full Text] [Related]
2. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
[TBL] [Abstract][Full Text] [Related]
3. FACEHBI: A Prospective Study of Risk Factors, Biomarkers and Cognition in a Cohort of Individuals with Subjective Cognitive Decline. Study Rationale and Research Protocols.
Rodriguez-Gomez O; Sanabria A; Perez-Cordon A; Sanchez-Ruiz D; Abdelnour C; Valero S; Hernandez I; Rosende-Roca M; Mauleon A; Vargas L; Alegret M; Espinosa A; Ortega G; Guitart M; Gailhajanet A; Sotolongo-Grau O; Moreno-Grau S; Ruiz S; Tarragona M; Serra J; Martin E; Peleja E; Lomeña F; Campos F; Vivas A; Gomez-Chiari M; Tejero MA; Giménez J; Pesini P; Sarasa M; Martinez G; Ruiz A; Tarraga L; Boada M
J Prev Alzheimers Dis; 2017; 4(2):100-108. PubMed ID: 29186280
[TBL] [Abstract][Full Text] [Related]
4. Cross-Cultural Longitudinal Study on Cognitive Decline (CLoCODE) for Subjective Cognitive Decline in China and Germany: A Protocol for Study Design.
Sheng C; Yang K; He B; Li T; Wang X; Du W; Hu X; Jiang J; Jiang X; Jessen F; Han Y
J Alzheimers Dis; 2022; 87(3):1319-1333. PubMed ID: 35431240
[TBL] [Abstract][Full Text] [Related]
5. Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial.
Chen GQ; Sheng C; Li YX; Yu Y; Wang XN; Sun Y; Li HY; Li XY; Xie YY; Han Y
BMC Neurol; 2016 May; 16():64. PubMed ID: 27176479
[TBL] [Abstract][Full Text] [Related]
6. Association between plasma exosome neurogranin and brain structure in patients with Alzheimer's disease: a protocol study.
He M; Sun L; Cao W; Yin C; Sun W; Liu P; Tan L; Xu Z; Zhao W
BMJ Open; 2020 Aug; 10(8):e036990. PubMed ID: 32801201
[TBL] [Abstract][Full Text] [Related]
7. From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.
Bessi V; Mazzeo S; Padiglioni S; Piccini C; Nacmias B; Sorbi S; Bracco L
J Alzheimers Dis; 2018; 63(4):1523-1535. PubMed ID: 29782316
[TBL] [Abstract][Full Text] [Related]
8. Beneficial Effects of Brain Reserve on Cognition in Individuals with Subjective Cognitive Decline from the SILCODE Study.
Chen G; Liu C; Yang K; Li Y; Sheng C; Xie Y; Hu X; Jiang J; Han Y
J Alzheimers Dis; 2020; 75(4):1203-1210. PubMed ID: 32417777
[TBL] [Abstract][Full Text] [Related]
9. Altered Gut Microbiota in Adults with Subjective Cognitive Decline: The SILCODE Study.
Sheng C; Lin L; Lin H; Wang X; Han Y; Liu SL
J Alzheimers Dis; 2021; 82(2):513-526. PubMed ID: 34024839
[TBL] [Abstract][Full Text] [Related]
10. Urinary Alzheimer-Associated Neuronal Thread Protein is not Elevated in Patients with Subjective Cognitive Decline and Patients with Depressive State.
Li Y; Kang M; Wang H; Jin H; Wang X; Gan W; Zhao M; Zhao X; Wang R; Han Y
J Alzheimers Dis; 2019; 71(4):1115-1123. PubMed ID: 31524164
[TBL] [Abstract][Full Text] [Related]
11. MRI-based comparative study of different mild cognitive impairment subtypes: protocol for an observational case-control study.
Yu Y; Zhao W; Li S; Yin C
BMJ Open; 2017 Mar; 7(3):e013432. PubMed ID: 28274963
[TBL] [Abstract][Full Text] [Related]
12. Differences in Functional Brain Networks Between Subjective Cognitive Decline with and without Worry Groups: A Graph Theory Study from SILCODE.
Liu Y; Li Z; Jiang X; Du W; Wang X; Sheng C; Jiang J; Han Y
J Alzheimers Dis; 2021; 84(3):1279-1289. PubMed ID: 34657889
[TBL] [Abstract][Full Text] [Related]
13. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
14. Face-Name Associative Recognition Deficits in Subjective Cognitive Decline and Mild Cognitive Impairment.
Polcher A; Frommann I; Koppara A; Wolfsgruber S; Jessen F; Wagner M
J Alzheimers Dis; 2017; 56(3):1185-1196. PubMed ID: 28106560
[TBL] [Abstract][Full Text] [Related]
15. Identification of odors, faces, cities and naming of objects in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer´s disease: a longitudinal study.
Tahmasebi R; Zehetmayer S; Pusswald G; Kovacs G; Stögmann E; Lehrner J
Int Psychogeriatr; 2019 Apr; 31(4):537-549. PubMed ID: 30236169
[TBL] [Abstract][Full Text] [Related]
16. Urine AD7c-NTP Predicts Amyloid Deposition and Symptom of Agitation in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
Zhang N; Zhang L; Li Y; Gordon ML; Cai L; Wang Y; Xing M; Cheng Y
J Alzheimers Dis; 2017; 60(1):87-95. PubMed ID: 28777752
[TBL] [Abstract][Full Text] [Related]
17. Association of plasma apolipoproteins and levels of inflammation-related factors with different stages of Alzheimer's disease: a cross-sectional study.
Wang T; Wang X; Yao Y; Zhao C; Yang C; Han Y; Cai Y
BMJ Open; 2022 Apr; 12(4):e054347. PubMed ID: 35387811
[TBL] [Abstract][Full Text] [Related]
18. Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment.
Fernández-Blázquez MA; Ávila-Villanueva M; Maestú F; Medina M
J Alzheimers Dis; 2016 Mar; 52(1):271-81. PubMed ID: 27060949
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.
Wolfsgruber S; Polcher A; Koppara A; Kleineidam L; Frölich L; Peters O; Hüll M; Rüther E; Wiltfang J; Maier W; Kornhuber J; Lewczuk P; Jessen F; Wagner M
J Alzheimers Dis; 2017; 58(3):939-950. PubMed ID: 28527210
[TBL] [Abstract][Full Text] [Related]
20. Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease based on multicenter diffusion tensor imaging.
Brueggen K; Dyrba M; Cardenas-Blanco A; Schneider A; Fliessbach K; Buerger K; Janowitz D; Peters O; Menne F; Priller J; Spruth E; Wiltfang J; Vukovich R; Laske C; Buchmann M; Wagner M; Röske S; Spottke A; Rudolph J; Metzger CD; Kilimann I; Dobisch L; Düzel E; Jessen F; Teipel SJ;
J Neurol; 2019 Oct; 266(10):2465-2474. PubMed ID: 31227891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
